70710-2152 : Beizray 20 mg/ml Intravenous Injection, Solution
| NDC: | 70710-2152 |
| Labeler: | Zydus Pharmaceuticals USA Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Beizray |
| Dosage Form: | Intravenous Injection, Solution |
| Application #: | NDA218711 |
| Rev. Date: |
NDC Package Codes:
- 70710-2152-1: 1 VIAL, GLASS IN 1 CARTON (70710‑2152‑1) / 4 ML IN 1 VIAL, GLASS
Active Ingredients:
- Docetaxel Anhydrous
Dosage Strength:
- 20 mg/mL
Pharmaceutical Classes:
- Microtubule Inhibition [PE]
- Microtubule Inhibitor [EPC]
Related Products:
Based on records with the same trade name.- 70710-2091 BeizrayBeizray Kit by Zydus Pharmaceuticals USA Inc.
- 70710-2092 Beizray 20 mg/ml Intravenous Injection, Solution by Zydus Pharmaceuticals USA Inc.
- 70710-2093 BeizrayBeizray Kit by Zydus Pharmaceuticals USA Inc.
- 83513-008 Beizray 20 mg/ml Intravenous Injection, Solution by Zhuhai Beihai Biotech Co., Ltd.
- 83513-009 Beizray 20 mg/ml Intravenous Injection, Solution by Zhuhai Beihai Biotech Co., Ltd.
- 83513-010 BeizrayBeizray Intravenous Kit by Zhuhai Beihai Biotech Co., Ltd.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 70710-2142Next: 70712-101 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.